← All trials
NCT05019287
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 17, 2021
- Primary completion
- May 21, 2021
- Completion date
- Jun 9, 2021
- First posted
- Aug 24, 2021
- Last posted
- Sep 2, 2021
- Enrollment
- 29
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Avicenna Medical CenterLead sponsor
- University of TehranCollaborator
- Tehran University of Medical ScienceStudy chair
- Tehran University of Medical ScienceOverall official - principal investigator
- Tehran University of Medical ScienceStudy chair
- Tehran University of Medical ScienceStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.